ASMB - Company ID 0001426800
The table below shows ASSEMBLY BIOSCIENCES, INC.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $72.30M | $28.52M | $7.16M | $0.00 | $6.25M | $79.11M |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $64.81M | $55.93M | $48.90M | $69.98M | $68.52M | $106.82M |
| SG&A |
ASSEMBLY BIOSCIENCES, INC. reported annual revenue of $72.30M for fiscal year 2025. That is up 153.5% from $28.52M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $19.61M |
| $18.01M |
| $22.91M |
| $24.13M |
| $28.78M |
| $37.06M |
| Operating income | -$12.12M | -$45.42M | -$64.65M | -$94.11M | -$132.69M | -$64.78M |
| Income tax | $0.00 | $330.00K | $33.00K | $0.00 | -$2.53M | $0.00 |
| Net income | -$6.12M | -$40.18M | -$61.23M | -$93.09M | -$129.85M | -$62.15M |
| EPS (diluted) | -$0.55 | -$6.69 | -$13.38 | -$23.08 | -$3.00 | - |